Nifty
Sensex
:
:
14238.90
48347.59
-133.00 (-0.93%)
-530.95 (-1.09%)

Pharmaceuticals & Drugs

Rating :
64/99  (View)

BSE: 524654 | NSE: Not Listed

94.00
1.40 (1.51%)
25-Jan-2021 | 4:01PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  94.90
  •  94.90
  •  88.15
  •  92.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  5334
  •  5.01
  •  108.00
  •  32.65

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 58.18
  • 14.51
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 63.52
  • 0.64%
  • 0.99

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 54.37%
  • 0.00%
  • 29.72%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 15.91%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.07
  • -0.16
  • 3.97

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -4.82
  • -10.94
  • -0.36

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -15.20
  • -27.66
  • -8.15

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 15.27
  • 16.75

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.18
  • 0.44
  • 0.66

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.79
  • 4.30
  • 6.54

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Net Sales
21.75
16.37
32.86%
18.65
15.52
20.17%
16.00
14.02
14.12%
15.65
15.84
-1.20%
Expenses
18.38
14.74
24.69%
16.21
14.60
11.03%
14.40
12.79
12.59%
14.14
14.81
-4.52%
EBITDA
3.37
1.63
106.75%
2.44
0.92
165.22%
1.60
1.23
30.08%
1.51
1.03
46.60%
EBIDTM
15.49%
9.96%
13.14%
5.93%
10.00%
8.77%
14.01%
6.50%
Other Income
0.01
0.22
-95.45%
0.17
0.26
-34.62%
0.34
0.27
25.93%
0.21
0.09
133.33%
Interest
0.03
0.27
-88.89%
0.04
0.16
-75.00%
0.15
0.15
0.00%
0.19
0.14
35.71%
Depreciation
1.09
1.15
-5.22%
1.05
0.75
40.00%
1.03
0.90
14.44%
1.32
0.34
288.24%
PBT
2.26
0.43
425.58%
1.53
0.27
466.67%
2.94
0.45
553.33%
0.21
0.64
-67.19%
Tax
0.64
0.20
220.00%
0.35
0.12
191.67%
0.46
0.10
360.00%
0.10
-0.27
-
PAT
1.62
0.23
604.35%
1.18
0.15
686.67%
2.48
0.35
608.57%
0.11
0.91
-87.91%
PATM
7.45%
1.41%
6.33%
0.97%
15.50%
2.50%
7.11%
5.74%
EPS
2.60
0.37
602.70%
1.91
0.24
695.83%
3.98
0.56
610.71%
28.29
1.46
1,837.67%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 20
Mar 19
Mar 18
Net Sales
72.05
61.55
59.78
54.76
Net Sales Growth
16.68%
2.96%
9.17%
 
Cost Of Goods Sold
4,671.01
28.03
26.49
23.81
Gross Profit
-4,598.96
33.52
33.29
30.95
GP Margin
-6,383.01%
54.46%
55.69%
56.52%
Total Expenditure
63.13
56.11
54.73
49.22
Power & Fuel Cost
-
8.16
8.89
6.79
% Of Sales
-
13.26%
14.87%
12.40%
Employee Cost
-
5.91
5.57
5.23
% Of Sales
-
9.60%
9.32%
9.55%
Manufacturing Exp.
-
5.56
5.92
4.80
% Of Sales
-
9.03%
9.90%
8.77%
General & Admin Exp.
-
3.51
3.63
3.07
% Of Sales
-
5.70%
6.07%
5.61%
Selling & Distn. Exp.
-
4.46
3.92
5.20
% Of Sales
-
7.25%
6.56%
9.50%
Miscellaneous Exp.
-
0.49
0.30
0.32
% Of Sales
-
0.80%
0.50%
0.58%
EBITDA
8.92
5.44
5.05
5.54
EBITDA Margin
12.38%
8.84%
8.45%
10.12%
Other Income
0.73
0.95
1.14
0.81
Interest
0.41
0.91
0.53
0.33
Depreciation
4.49
4.12
3.20
4.33
PBT
6.94
1.37
2.46
1.68
Tax
1.55
0.51
0.15
0.57
Tax Rate
22.33%
37.23%
7.25%
33.93%
PAT
5.39
0.86
1.92
1.11
PAT before Minority Interest
5.39
0.86
1.92
1.11
Minority Interest
0.00
0.00
0.00
0.00
PAT Margin
7.48%
1.40%
3.21%
2.03%
PAT Growth
228.66%
-55.21%
72.97%
 
Unadjusted EPS
8.69
1.39
3.10
1.79

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Shareholder's Funds
55.62
55.49
54.32
Share Capital
6.23
6.23
6.23
Total Reserves
49.39
49.26
48.09
Non-Current Liabilities
1.08
1.23
1.88
Secured Loans
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
Long Term Provisions
0.14
0.15
0.15
Current Liabilities
17.99
16.42
14.86
Trade Payables
6.96
8.25
12.05
Other Current Liabilities
4.65
2.63
1.84
Short Term Borrowings
6.26
5.41
0.00
Short Term Provisions
0.11
0.13
0.96
Total Liabilities
74.69
73.14
71.06
Net Block
23.81
24.37
21.88
Gross Block
69.64
66.07
61.49
Accumulated Depreciation
45.83
41.71
39.61
Non Current Assets
36.98
34.79
29.42
Capital Work in Progress
2.11
2.45
1.03
Non Current Investment
5.57
5.07
5.07
Long Term Loans & Adv.
4.69
2.09
0.48
Other Non Current Assets
0.79
0.81
0.96
Current Assets
37.71
38.36
41.64
Current Investments
0.00
0.00
0.00
Inventories
5.28
4.32
7.70
Sundry Debtors
30.36
32.20
31.26
Cash & Bank
0.93
0.50
0.91
Other Current Assets
1.14
0.07
0.22
Short Term Loans & Adv.
1.04
1.27
1.54
Net Current Assets
19.72
21.94
26.78
Total Assets
74.69
73.15
71.06

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Cash From Operating Activity
7.20
2.10
5.35
PBT
1.37
2.07
1.68
Adjustment
4.85
3.89
4.58
Changes in Working Capital
1.64
-3.07
-0.92
Cash after chg. in Working capital
7.86
2.89
5.35
Interest Paid
0.00
0.00
0.00
Tax Paid
-0.66
-0.79
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
Cash From Investing Activity
-5.74
-7.06
-0.93
Net Fixed Assets
-3.23
-6.00
Net Investments
-0.50
-0.01
Others
-2.01
-1.05
Cash from Financing Activity
-1.19
4.28
-3.93
Net Cash Inflow / Outflow
0.27
-0.68
0.49
Opening Cash & Equivalents
0.06
0.74
0.25
Closing Cash & Equivalent
0.33
0.06
0.74

Financial Ratios

Standalone /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Book Value (Rs.)
89.24
89.04
87.16
ROA
1.16%
2.66%
1.56%
ROE
1.54%
3.50%
2.05%
ROCE
3.71%
4.51%
3.71%
Fixed Asset Turnover
0.91
0.94
0.89
Receivable days
185.47
193.73
208.38
Inventory Days
28.45
36.68
51.33
Payable days
48.48
69.74
83.44
Cash Conversion Cycle
165.44
160.67
176.26
Total Debt/Equity
0.11
0.10
0.00
Interest Cover
2.51
4.90
6.03

News Update


  • Natural Capsules - Quarterly Results
    7th Nov 2020, 18:12 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.